Press release
Leading Growth Driver in the Chikungunya Market in 2025: Increasing Global Incidence Of Mosquito-Borne Diseases Driving Market Growth Driver's Influence
Chikungunya
Rising prevalence of mosquito-borne diseases is expected to propel the growth of the chikungunya market. The global incidence of mosquito-borne diseases like chikungunya is increasing due to climate change, urbanization, and other environmental factors. The treatment for chikungunya helps alleviate symptoms and reduce the risk of complications, improving patient recovery. For instance, in December 2024, the UK Health Security Agency reported a 201% increase in dengue cases among returning travelers in the UK, illustrating the growing public health challenges posed by mosquito-borne diseases. This increasing incidence is driving the chikungunya market's growth.
Get Your Chikungunya Market Report Here:
https://www.thebusinessresearchcompany.com/report/chikungunya-global-market-report
How will the growth rate of the chikungunya market shape industry trends by 2034?
The chikungunya market has also grown steadily, expected to expand from $0.59 billion in 2024 to $0.65 billion in 2025 at a CAGR of 9.8%. Factors contributing to past growth include rising per capita healthcare expenditures, the increasing prevalence of emerging infectious diseases, higher disposable incomes, climate change, and greater awareness of mosquito-borne diseases.
The chikungunya market is projected to experience steady growth, expanding to $0.93 billion by 2029 at a CAGR of 9.4%. Growth drivers include an international increase in clinical trials, a growing elderly population, a rising demand for immunization, increased government and non-government initiatives, higher investments from public and private sectors, and supportive policy frameworks. Key trends anticipated during the forecast period include advancements in biotechnology for vaccine development, the emergence of new vaccine opportunities, the integration of CRISPR and AI for innovative solutions, strategic collaborations among pharmaceutical players, and the incorporation of telemedicine services.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21137&type=smp
What trends are poised to drive the future success of the chikungunya market?
In the chikungunya market, companies are advancing innovative vaccines to prevent disease outbreaks and enhance immunity. In November 2023, Valneva SE received FDA approval for IXCHIQ, a live attenuated chikungunya vaccine, under accelerated approval based on anti-CHIKV antibody titers. The vaccine, administered as a single-dose injection, uses a weakened form of the virus to stimulate an immune response without causing disease, potentially offering long-term protection.
Which primary segments of the chikungunya market are driving growth and industry transformations?
The chikungunya market covered in this report is segmented -
1) By Type: Antiviral Drugs, Herbal And Complementary Treatments, Supportive Care, Vaccines
2) By Product Form: Liquid Form, Powder, Solid Form
3) By Disease Stage: Acute, Chronic, Post-Infection
4) By Sales Channel: Hospital Pharmacies, Online Pharmacies, Retail Pharmacies, Supermarkets
5) By End User: Caregivers, Healthcare Professionals, Patients
Subsegments:
1) By Antiviral Drugs: Nucleoside Analogues, Protease Inhibitors
2) By Herbal And Complementary Treatments: Ayurvedic Remedies, Homeopathic Treatments, Traditional Chinese Medicine
3) By Supportive Care: Pain Relievers (NSAIDs, Acetaminophen), Fluid Therapy, Physiotherapy
4) By Vaccines: Live-Attenuated Vaccines, Inactivated Vaccines, mRNA-Based Vaccines
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21137
Which geographical regions are pioneering growth in the chikungunya market?
North America was the largest region in the chikungunya market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chikungunya market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Who are the influential players reshaping the chikungunya market landscape?
Major companies operating in the chikungunya market are F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Thermo Fisher Scientific Inc., Takeda Pharmaceutical Company Limited, Quest Diagnostics Incorporated, Eurofins Scientific SE, Grifols Diagnostic Solutions Inc., bioMérieux SA, Bio-Rad Laboratories Inc., DiaSorin S.p.A., Euroimmun AG, Evotec SE, Valneva SE, ELITechGroup S.A.S., Vaxart Inc., BioPerfectus Biotechnology Co. Ltd., CTK Biotech Inc., Creative Diagnostics Inc., Inovio Pharmaceuticals Inc., Biotrol Laboratories Pvt. Ltd.
Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=21137&type=smp
What Is Covered In The Chikungunya Global Market Report?
•Market Size Forecast: Examine the chikungunya market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the chikungunya market for a structured understanding.
•Key Players Overview: Analyze major players in the chikungunya market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the chikungunya market.
•Segment Contributions: Evaluate how different segments drive overall growth in the chikungunya market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the chikungunya market.
•Industry Challenges: Identify potential risks and obstacles affecting the chikungunya market.
•Competitive Landscape: Review strategic developments in the chikungunya market, including expansions, agreements, and new product launches.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Leading Growth Driver in the Chikungunya Market in 2025: Increasing Global Incidence Of Mosquito-Borne Diseases Driving Market Growth Driver's Influence here
News-ID: 3934427 • Views: …
More Releases from The Business Research Company
Global Semantic Knowledge Graphing Market Projected to Grow at 12.5% CAGR, Reach …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Semantic Knowledge Graphing Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
In recent times, there has been significant growth in the market size of semantic knowledge graphing. It is anticipated that the market will expand from $1.49 billion in 2024 to $1.7 billion in 2025,…
Global Security Analytics Industry Outlook 2025-2029: Market Set to Cross $35.7 …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Security Analytics Market Through 2025?
The market size for security analytics has rapidly expanded in the recent past. From $17 billion in 2024, it is projected to swell up to $19.74 billion in 2025, representing a compound annual growth rate (CAGR) of…
Remote Work Revolution Fueling The Surge In Robotic Process Automation (RPA) Tec …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Robotic Process Automation (RPA) In Information Technology Industry Market Size Be by 2025?
The market size of Robotic Process Automation (RPA) in Information Technology has seen an explosive growth recently. The market is projected to expand from $1.42 billion in 2024 to $1.78 billion in 2025,…
Soaring Demand Set to Propel Remote Firmware Market to $13.58 Billion by 2029
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Remote Firmware Market Size By 2025?
The market size of remote firmware has experienced substantial growth in the past few years. It is projected to increase from $7.35 billion in 2024 to $8.37 billion in 2025, with a compound annual growth rate (CAGR) of 13.8%.…
More Releases for Chikungunya
Chikungunya market is expected to reach USD 1.4 billion by 2034
Chikungunya is a mosquito-borne viral disease caused by the chikungunya virus (CHIKV), transmitted primarily by Aedes aegypti and Aedes albopictus. The infection is characterized by sudden high fever, severe joint pain, rash, headache, and fatigue. While rarely fatal, chikungunya often leads to chronic arthritis-like symptoms lasting months to years, creating a significant burden on healthcare systems.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/71953
Global spread is accelerating due to…
Chikungunya Market Forecast 2025-2034: Comprehensive Analysis And Growth Opportu …
We've updated all our reports with current data on tariff changes, trade developments, and supply chain shifts affecting key industries.
What Is the Projected Growth of the Chikungunya Market?
In recent times, there has been robust growth in the chikungunya market size. It is projected to expand from $0.59 billion in 2024 to $0.65 billion in 2025, with a compound annual growth rate (CAGR) of 9.8%. Factors that have contributed to this…
Chikungunya Pipeline Insight 2025: 10+ Advancing Therapies and Key Companies in …
The therapeutic landscape for Chikungunya, a viral disease transmitted by mosquitoes that causes severe joint pain, fever, and rash, is rapidly evolving, fueled by advancements in antiviral research and vaccine development. Leading biopharmaceutical companies such as Valneva, Moderna Therapeutics, Themis Bioscience, FIT Biotech, Bharat Biotech, and Emergex Vaccines are at the forefront of developing innovative therapies, targeting various stages of the virus lifecycle, immune modulation, and pain management to alleviate…
Chikungunya Fever Global Clinical Trials Review, H2, 2018: Researchmoz.us
Researchmoz added Most up-to-date research on "Chikungunya Fever Global Clinical Trials Review, H2, 2018" to its huge collection of research reports. An insight on the important factors and trends influencing the market.
Latest clinical trial report, Chikungunya Fever Global Clinical Trials Review, H2, 2018" provides an overview of Chikungunya Fever clinical trials scenario. This report provides top line data relating to the clinical trials on Chikungunya Fever. Report includes an overview…
Chikungunya Fever Market Segmentation 2018 with Recent Trend by 2023
Chikungunya Fever Market - Highlights
Chikungunya fever is a mosquito borne disease. The caU.S.Ative agent is a RNA virus that belongs to the alphavirus genus of the family Togaviridae. The transmission of the disease occurs from human to human by the bites of infected female mosquitoes. Most commonly, the mosquitoes involved are Aedes aegypti and Aedes albopictus. The symptoms of the disease includes muscle pain, headache, nausea, fatigue and rash.
There is…
Chikungunya Fever Market Worldwide Segmentation with Top Key Merchant – Avail …
Chikungunya Fever Market - Highlights
Chikungunya fever is a mosquito borne disease. The caU.S.Ative agent is a RNA virus that belongs to the alphavirus genus of the family Togaviridae. The transmission of the disease occurs from human to human by the bites of infected female mosquitoes. Most commonly, the mosquitoes involved are Aedes aegypti and Aedes albopictus. The symptoms of the disease includes muscle pain, headache, nausea, fatigue and rash.
There is…
